An autologous T-cell vaccine for the early treatment of patients with relapsing remitting multiple sclerosis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
An autologous T-cell vaccine for the early treatment of patients with relapsing remitting multiple sclerosis.
If you have a Hayes login, click here to view the full report on the Knowledge Center.